Background: Signet ring carcinoma is an exceedingly rare and aggressive variant of primary bladder carcinoma. The cytomorphologic features of this rare entity in urinary specimens have not been well characterized. Methods: Twenty-seven cases of signet ring cell carcinoma of the urinary bladder were identified from the pathology archives of The Johns Hopkins Hospital (1989–2011). Of these, 6 cases with prior urinary cytology specimens were studied. Results: There were 5 males and 1 female, with a mean age of 62 years. The presenting complaints included hematuria with or without symptoms of bladder irritation. Histopathologically, there were 5 cases of primary bladder carcinoma and 1 case of metastatic colonic signet ring cell carcinoma. The salient cytomorphologic features included scattered malignant epithelial cells, displaying distinct cell borders, abundant cytoplasm with a single large, discrete mucin vacuole, and eccentric irregular nuclei with prominent nucleoli. Primary adenocarcinoma additionally revealed a few intact malignant glandular epithelial fragments. Metastatic colonic signet ring cell carcinoma displayed predominantly singly dispersed malignant cells with eccentrically placed, oval nuclei with occasional small nucleoli and a moderate amount of vacuolated cytoplasm. Conclusion: Signet ring cell carcinomas are rarely encountered in urinary cytology. The differential diagnosis includes distended histiocytes or degenerated urothelial cells, primary signet ring cell carcinoma, and metastatic adenocarcinoma.

1.
Saphir O: Signet-ring cell carcinoma of the urinary bladder. Am J Pathol 1955;31:223–231.
2.
Naeim F, Schlezinger RM, de la Maza LM: Primary signet ring cell carcinoma of the bladder: report of a case and review of the literature. J Urol 1972;108:274–276.
3.
Grignon DJ, Ro JY, Ayala AG, Johnson DE: Primary signet-ring cell carcinoma of the urinary bladder. Am J Clin Pathol 1991;95:13–20.
4.
Fiter L, Gimeno F, Martin L, Gomez Tejeda L: Signet-ring cell adenocarcinoma of the bladder. Urology 1993;41:30–33.
5.
Dhouib R, Khattech R, Sassi S, Ben Romdhane K: Primary signet ring cell carcinoma of the bladder. Ann Pathol 1999;19:78–79.
6.
Akamatsu S, Takahashi A, Ito M, Ogura K: Primary signet-ring cell carcinoma of the urinary bladder. Urology 2010;75:615–618.
7.
Egevad L, Hakansson U, Grabe M, Ehrnstrom R: Urachal signet-cell adenocarcinoma. Scand J Urol Nephrol 2009;43:88–91.
8.
Gopalan A, Sharp DS, Fine SW, Tickoo SK, Herr HW, Reuter VE, Olgac S: Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation. Am J Surg Pathol 2009;33:659–668.
9.
Busto Martin LA, Janeiro Pais M, Gonzalez Dacal J, Chantada Abal V, Busto Castanon L: Signet-ring cell adenocarcinoma of the bladder: case series between 1990–2009. Arch Esp Urol 2010;63:150–153.
10.
Thomas DG, Ward AM, Williams JL: A study of 52 cases of adenocarcinoma of the bladder. Br J Urol 1971;43:4–15.
11.
Jacobo E, Loening S, Schmidt JD, Culp DA: Primary adenocarcinoma of the bladder: a retrospective study of 20 patients. J Urol 1977;117:54–56.
12.
Wright JL, Porter MP, Li CI, Lange PH, Lin DW: Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder. Cancer 2006;107:721–728.
13.
Sanchez Gomez E, Cruz Navarro N, Rodriguez Perez AJ, Catalina Fernandez I, Montanes Medina P, Pascual del Pobil Moreno JL, Mendoza Garcia E: Primary signet ring cell adenocarcinoma of the bladder. Arch Esp Urol 1993;46:19–22
14.
DeMay RM, Grathwohl MA: Signet-ring-cell (colloid) carcinoma of the urinary bladder. Cytologic, histologic and ultrastructural findings in one case. Acta Cytol 1985;29:132–136.
15.
Kim SS, Choi YD, Nam JH, Kwon DD, Juhng SW, Choi C: Cytologic features of primary signet ring cell carcinoma of the bladder: a case report. Acta Cytol 2009;53:309–312.
16.
Shinagawa T, Tadokoro M, Abe M, Koshitaka Y, Kouno S, Hoshino T: Papillary urothelial carcinoma of the urinary bladder demonstrating prominent signet-ring cells in a smear. A case report. Acta Cytol 1998;42:407–412.
17.
Kitamura H, Sumikawa T, Fukuoka H, Kanisawa M: Primary signet-ring cell carcinoma of the urinary bladder. Report of two cases with histochemical studies. Acta Pathol Jpn 1985;35:675–686.
18.
Alvarado-Cabrero I, Perez-Montiel D, Hes O: Multicystic urothelial carcinoma of the bladder with gland-like lumina and with signet-ring cells. A case report. Diagn Pathol 2008;3:36.
19.
Cimino-Mathews A, Ali SZ: Metastatic urothelial carcinoma with signet ring features: cytomorphologic findings in abdominal paracentesis. Diagn Cytopathol 2011;39:132–134.
20.
Wu JM, Ali SZ: Significance of ‘signet-ring cells’ seen in exfoliative and aspiration cytopathology. Diagn Cytopathol 2010;38:413–418.
21.
Thomas AA, Stephenson AJ, Campbell SC, Jones JS, Hansel DE: Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder. Hum Pathol 2009;40:108–116.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.